Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > not to get too excited
View:
Post by Bartstar on Feb 05, 2010 12:15pm

not to get too excited

Great news, yes even greater news within the next 2 months, but really relax with the mania. The stock has been scarred by the past and the institutions that will be putting their money here will wait until they see some fundamental business net profit before they start pouring money into the share price. We may see some price surging up to .60 or .70 but the real deal will come through when they start turning all those losses into gains, either they will rise on fundamentals or they will be bought out by a major. Frankly I wouldn't be surprised to see roche knocking at the door in the short future.
Comment by biodelatech on Feb 05, 2010 12:35pm
yeah sure roche.we are all yearning for the swiss traitors to come back.
Comment by culater on Feb 05, 2010 3:03pm
ROCHE, the slightest hint of Roche back knocking at the door would drive this stock to $5.00 overnight.  I think the share price would welcome any interest by a bigger Pharma company.  IMHOculater
Comment by wrongturn on Feb 05, 2010 3:39pm
The Roche deal is dead and they will NOT be back.The question not becomes when will Paladin take us over?  Just pray the share price keeps climbing so it becomes more expensive to buys us out.
Comment by professional11 on Feb 05, 2010 7:09pm
https://www.fiercepharma.com/story/novartis-shopping-its-roche-stake/2010-02-03 Novartis is selling off its Roche shares to pay for the Alcon purchase. This is good news for ISA and Lux. Novartis/Alcon (#1 in kidney transplant, #1 in eye drugs) is soon going to be a 100% competitor with Roche. If Voclosporine receives FDA-approval in October, look for Novartis/Alcon to purchase ISA/Lux by years ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities